Determination of dose enhancement caused by AuNPs with Xoft(®) Axxent(®) Electronic (eBx™) and conventional brachytherapy: in vitro study

PURPOSE: The purpose of this study was to determine dose enhancement (DE) and the possible clinical benefits associated with the inclusion of gold nanoparticles (AuNPs) in cancer cells irradiated by either an (192)Ir brachytherapy source or a Xoft(®) Axxent(®) Electronic (eBx™) Brachytherapy. PATIEN...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahhoseini, Elham, Ramachandran, Prabhakar, Patterson, William Roy, Geso, Moshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165788/
https://www.ncbi.nlm.nih.gov/pubmed/30310276
http://dx.doi.org/10.2147/IJN.S174624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165788/
https://www.ncbi.nlm.nih.gov/pubmed/30310276
http://dx.doi.org/10.2147/IJN.S174624

Ejemplares similares